<DOC>
	<DOCNO>NCT02757287</DOCNO>
	<brief_summary>Currently , control ovarian stimulation ( COS ) oocyte donor perform daily injection gonadotropin ( recombinant FSH ) plus GnRH Antagonist usually form 5th-6th stimulation day ovulation induction bolus another injection gonadotropin-releasing hormone ( GnRH ) Agonist . Injections GnRH Antagonist avoid untimely luteinizing hormone ( LH ) surge spontaneous ovulation prior follicular aspiration . There preparation long-acting recombinant follicle stimulate hormone ( rFSH= ( corifollitropin alfa ( FSH-CTP ) , Elonva® , MSD ) , allow single subcutaneous injection substitute first 7 day daily gonadotropin injection . On hand , contraceptive oral progesterone ( Desogestrel , DSG ) available contraception , avoid LH surge . It describe usefulness orally administer medroxyprogesterone acetate , 10 mg inhibit endogenous LH surge IVF patient COS . In donor , administer single injection FSH-CTP oral desogestrel since first menstruation day , total number injection administer reduced less discomfort experience without adverse impact ovarian response . No description hormonal ovarian response protocol publish</brief_summary>
	<brief_title>Desogestrel ( DSG ) Corifollitropin ( FSH-CTP ) Alfa Ovarian Stimulation Donors</brief_title>
	<detailed_description>- oral desogestrel since first menstruation day , - single injection FSH-CTP 7th menstrual cycle day - routine monitoring ovarian response transvaginal ultrasound every second day pre-ovulatory bolus GnRH - Hormones measure day 7th menstrual cycle day , day pre-ovulatory bolus GnRH day bolus ( estradiol , FSH , Progesterone , LH ) - Quality Life questionnaire day bolus</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Population : donor ( 1835 ) candidate Donor program Fulfilling inclusión medical legal criterion ( RD Ley de transposición de la normativa europea la legislación española 9/2014 ) Who undergo previously convencional COS ( control ovarian stimulation ) FSHCTP daily antagonist injection Given sign consent form . Previous low response COS Previous ovarian hyperstimulation syndrome . Ovarian cyst .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Ovarian stimulation</keyword>
	<keyword>LH inhibition</keyword>
</DOC>